Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells
Food Frontiers · 2025-09 · 6 (5) · 2241-2254
DOI: 10.1002/fft2.70084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Food Frontiers, online erschienen am 29.07.2025. Verfasst von Lining Chen und 9 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Tumor cells have a competitive edge in nutrient uptake, leading to immune cell nutrient deprivation within the tumor microenvironment (TME) and suppressing anti‐tumor immunity. However, the key nutrient deprived by intestinal tumor cells and effective intervention strategies remains unidentified. Using organoid models and metabolomics, we clarified riboflavin as the most preferential nutrient for intestinal tumor cells over normal epithelial cells. After confirming in vitro that riboflavin supplementation did not promote tumor cell proliferation, we found in vivo that drinking water with riboflavin effectively inhibited murine colorectal tumor growth with enhanced intra‐tumoral CD8 + T‐cell cytotoxicity. We further demonstrated the indispensable role of adequate riboflavin in maintaining effector CD8 + T cells and revealed intestinal tumor cells overexpressed the riboflavin transporter SLC52A2, depleting riboflavin from CD8 + T cells and dampening their cytotoxicity, which can be restored by riboflavin supplementation. Our work clarified the critical nutrient and immune evasion mechanism, suggesting riboflavin supplementation as potential therapy to enhance anti‐tumor immunity in colorectal cancer.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Chen, L., Lu, Y., Xue, P., Lin, Y., Zhang, Z., Wang, Y., Zhang, Y., Quan, H., Wang, Y., & Guo, H. (2025). Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells. Food Frontiers, 6(5), 2241-2254. https://doi.org/10.1002/fft2.70084
Vancouver
Chen L, Lu Y, Xue P, Lin Y, Zhang Z, Wang Y, et al. Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells. Food Frontiers. 2025;6(5):2241-2254. doi:10.1002/fft2.70084
BibTeX
@article{Chen2025,
author = {Chen, Lining and Lu, Yao and Xue, Peng and Lin, Yingying and Zhang, Zhen and Wang, Yuqi and Zhang, Yuning and Quan, Heng and Wang, Yiran and Guo, Huiyuan},
title = {Dietary Riboflavin Supplementation Suppresses Colorectal Cancer Progression by Restoring the Function Effector of CD8 + T Cells},
journal = {Food Frontiers},
year = {2025},
volume = {6},
number = {5},
pages = {2241--2254},
doi = {10.1002/fft2.70084}
}
EUVIMED